Acerus: Q1 Earnings Snapshot

May 10, 2022 GMT

MISSISSAUGA, Ontario (AP) _ Acerus Pharmaceuticals Corporation (ASPCD) on Tuesday reported a loss of $7 million in its first quarter.

On a per-share basis, the Mississauga, Ontario-based company said it had a loss of less than 1 cent.

The drugmaker posted revenue of $782,000 in the period.

The company’s shares closed at $3.90. A year ago, they were trading at $8.70.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ASPCD at